Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,128 | 12,546 | 13,206 | 13,116 | 14,100 |
| Receivables | 145,208 | 143,227 | 145,376 | 143,150 | 152,386 |
| Inventories | 53,528 | 49,311 | 50,147 | 45,664 | 47,215 |
| Other current assets | 6,314 | 7,071 | 13,261 | 13,696 | 12,116 |
| TOTAL | $230,686 | $225,233 | $236,423 | $230,977 | $239,125 |
| Non-Current Assets | |||||
| PPE Net | 125,078 | 125,699 | 124,758 | 122,917 | 121,945 |
| Intangibles | 231,188 | 231,443 | 232,026 | 232,466 | 232,600 |
| Other Non-Current Assets | 200,744 | 199,143 | 198,553 | 62,467 | 72,927 |
| TOTAL | $557,010 | $556,285 | $555,337 | $417,850 | $427,472 |
| Total Assets | $787,696 | $781,518 | $791,760 | $648,827 | $666,597 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 42,191 | 41,995 | 44,467 | 41,155 | 41,012 |
| Accrued Expenses | 27,866 | 32,108 | 32,768 | 22,549 | 25,603 |
| Other current liabilities | 12,766 | 15,039 | 10,550 | 11,113 | 12,084 |
| TOTAL | $119,997 | $124,826 | $128,615 | $102,547 | $103,509 |
| Non-Current Liabilities | |||||
| Long Term Debt | 297,148 | 290,022 | 0 | 289,770 | 295,745 |
| Deferred Revenues | 12,348 | 14,070 | 18,430 | 17,325 | 15,265 |
| Other Non-Current Liabilities | 146,710 | 146,523 | 151,568 | 87,809 | 98,709 |
| TOTAL | $473,138 | $464,200 | $475,792 | $385,380 | $401,676 |
| Total Liabilities | $593,135 | $589,026 | $604,407 | $487,927 | $505,185 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,375 | 44,363 | 44,353 | 44,317 | 44,221 |
| Common Shares | 1,148 | 1,148 | 1,148 | 1,148 | 1,148 |
| Retained earnings | 174,615 | 175,285 | 172,266 | 156,130 | 171,617 |
| Other shareholders' equity | -2,700 | -2,005 | -1,145 | -816 | -3,002 |
| TOTAL | $194,561 | $192,492 | $187,353 | $160,900 | $161,412 |
| Total Liabilities And Equity | $787,696 | $781,518 | $791,760 | $648,827 | $666,597 |